Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
Molecular Weight:
190.15
Purity:
99.54%
CAS Number:
[1188-38-1]
Formula:
C6H10N2O5
Target:
Others
T0755
* VAT and and shipping costs not included. Errors and price changes excepted